RE:RE:RE:RE:RE:It Was Just A Typo
My god some people are so full of themselves and now more predictions.
BTW the poa is a mistake and is not in need of a correction and the company considers the matter closed and is a non issue.
And why are some still believing that MC exercised 350k options when it does not show on sedi or any other docs or in the quartelry reports under their holdings.
Just can't admit their mistakes but like to tell everyone else that they are wrong.
Time to move on and do not think that panc has taken a back seat at all. Today's announcement is only the start of guidance as we do not know the number of patients or the use of biomarkers, the sites or who will even possibly partner.
Still thinking that the scaa trial is the quickest to approval and that Roche will be the one to step up with either a partner ship or BO. And as for timing , people have been predictiing a partnership or BO for a few years now so we can only hope that eventually it will happen.
So let's hope that they are negotiatiing in good faith and that they are in the blackout as indicated by the non declaration of the December 2023 options.